HistCite - DE Kuhl w/citing papers

Add FileX ?

Use wildcard '*' to add more than one file at a time. For example, if you have file1, file2, etc. all in the same folder or directory; first, locate one of the files with the [Browse...] button. Then alter the file path in the box above to include '*' character (eg. file*). Wildcard '?' to blanket only one character works too.
Note: In Windows you can select multiple files and "drag and drop" them onto HistCite icon or shortcut. The program would start and load those files.

#	Date / Author / Journal	LCS	GCS	LCR	CR
501	9662 Zhou Y, Endres CJ, Brasic JR, Huang SC, Wong DF Linear regression with spatial constraint to generate parametric images of ligand-receptor dynamic PET studies with a simplified reference tissue model NEUROIMAGE. 2003 APR; 18 (4): 975-989	14	47	27	54
502	9812 Buchpiguel CA The role of functional neuroimaging methods in focal epilepsy - Evaluation under normal structural imaging findings ARQUIVOS DE NEURO-PSIQUIATRIA. 2003 SEP; 61: 88-92	0	0	27	55
503	9820 Sakamoto S, Tsuyuguchi N, Takami T, Morino M, Goto T, et al. Interictal patterns of cerebral glucose metabolism, perfusion, and magnetic field in mesial temporal lobe epilepsy EPILEPSIA. 2003 SEP; 44 (9): 1196-1206	2	11	27	50
504	10308 Holschneider DP, Maarek JMI Mapping brain function in freely moving subjects NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS. 2004 SEP; 28 (5): 449-461	0	5	27	136
505	10487 Fischman AJ Role of [F-18]-dopa-PET imaging in assessing movement disorders RADIOLOGIC CLINICS OF NORTH AMERICA. 2005 JAN; 43 (1): 93-+	2	9	27	99
506	10656 Mosconi L, Tsui WH, De Santi S, Li J, Rusinek H, et al. Reduced hippocampal metabolism in MCI and AD - Automated FDG-PET image analysis NEUROLOGY. 2005 JUN 14; 64 (11): 1860-1867	57	93	27	50
507	11653 Matsuda H The role of neuroimaging in mild cognitive impairment NEUROPATHOLOGY. 2007 DEC; 27 (6): 570-577	6	22	27	50
508	11820 Liang WS, Reiman EM, Valla J, Dunckley T, Beach TG, et al. Alzheimer's disease is associated with reduced expression of energy in posterior cingulate metabolism genes neurons PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2008 MAR 18; 105 (11): 4441-4446	10	45	27	54
509	11947 Goldman S Molecular imaging of dementia: Which means for which questions? MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE. 2008 AUG; 32 (8): 439-445	1	1	27	72
510	12130 Le Forestier N, Lacomblez L, Meininger V Parkinson disease and amyotrophic lateral sclerosis Tauopathies, TDP-43 and SOD mutations REVUE NEUROLOGIQUE. 2009 JAN; 165 (1): 15-30	0	0	27	258
#	Date / Author / Journal	LCS	GCS	LCR	CR
511	12699 Klein R, Beanlands RSB, deKemp RA Quantification of myocardial blood flow and flow reserve: Technical aspects JOURNAL OF NUCLEAR CARDIOLOGY. 2010 AUG; 17 (4): 555-570	0	0	27	68
512	1484 FARKAS T, WOLF AP, JAEGER J, BRODIE JD, CHRISTMAN DR, et al. REGIONAL BRAIN GLUCOSE-METABOLISM IN CHRONIC-SCHIZOPHRENIA - A POSITRON EMISSION TRANSAXIAL TOMOGRAPHIC STUDY ARCHIVES OF GENERAL PSYCHIATRY. 1984; 41 (3): 293-300	88	184	26	76
513	2058 ESSER PD IMPROVEMENTS IN SPECT TECHNOLOGY FOR CEREBRAL IMAGING SEMINARS IN NUCLEAR MEDICINE. 1985; 15 (4): 335-346	1	6	26	65
514	3301 SETTE G, BARON JC, MAZOYER B, LEVASSEUR M, PAPPATA S, et al. LOCAL BRAIN HEMODYNAMICS AND OXYGEN-METABOLISM IN CEREBROVASCULAR- DISEASE - POSITRON EMISSION TOMOGRAPHY BRAIN. 1989 AUG; 112: 931-951	28	124	26	54
515	3415 VAUPEL P, KALLINOWSKI F, OKUNIEFF P BLOOD-FLOW, OXYGEN AND NUTRIENT SUPPLY, AND METABOLIC MICROENVIRONMENT OF HUMAN-TUMORS - A REVIEW CANCER RESEARCH. 1989 DEC 1; 49 (23): 6449-6465	7	1473	26	214
516	3627 BLIN J, BARON JC, DUBOIS B, PILLON B, CAMBON H, et al. POSITRON EMISSION TOMOGRAPHY STUDY IN PROGRESSIVE SUPRANUCLEAR PALSY - BRAIN HYPOMETABOLIC PATTERN AND CLINICOMETABOLIC CORRELATIONS ARCHIVES OF NEUROLOGY. 1990 JUL; 47 (7): 747-752	64	172	26	48
517	3726 KUNG HF, OHMOMO Y, KUNG MP CURRENT AND FUTURE RADIOPHARMACEUTICALS FOR BRAIN IMAGING WITH SINGLE PHOTON-EMISSION COMPUTED-TOMOGRAPHY SEMINARS IN NUCLEAR MEDICINE. 1990 OCT; 20 (4): 290-302	7	26	26	129
518	4084 ALTMAN DI, VOLPE JJ POSITRON EMISSION TOMOGRAPHY IN NEWBORN-INFANTS CLINICS IN PERINATOLOGY. 1991 SEP; 18 (3): 549-562	1	4	26	52
519	4131 KUWERT T, HENNERICI M, LANGEN KJ, AULICH A, HERZOG H, et al. REGIONAL CEREBRAL GLUCOSE CONSUMPTION MEASURED BY POSITRON EMISSION TOMOGRAPHY IN PATIENTS WITH UNILATERAL THALAMIC INFARCTION CEREBROVASCULAR DISEASES. 1991 NOV-DEC; 1 (6): 327-336	11	21	26	42
520	4464 CHUGANI HT FUNCTIONAL BRAIN IMAGING IN PEDIATRICS PEDIATRIC CLINICS OF NORTH AMERICA. 1992 AUG; 39 (4): 777-799	12	49	26	84
#	Date / Author / Journal	LCS	GCS	LCR	CR
521	5205 COOK MJ, KILPATRICK C IMAGING IN EPILEPSY CURRENT OPINION IN NEUROLOGY. 1994 APR; 7 (2): 123-130	2	7	26	73
522	5530 STOPPE G, STAEDT J, KOGLER A, SCHUTZE R, KUNERT HJ, et al. TC-99M-HMPAO-SPECT IN THE DIAGNOSIS OF SENILE DEMENTIA OF ALZHEIMERS TYPE - A STUDY UNDER CLINICAL ROUTINE CONDITIONS JOURNAL OF NEURAL TRANSMISSION-GENERAL SECTION. 1995; 99 (1-3): 195-211	6	10	26	75
523	6314 Meltzer CC, Zubieta JK, Brandt J, Tune LE, Mayberg HS, et al. Regional hypometabolism in Alzheimer's disease as measured by positron emission tomography after correction for effects of partial volume averaging NEUROLOGY. 1996 AUG; 47 (2): 454-461	53	104	26	60
524	7820 Lamusuo S, Forss N, Ruottinen HM, Bergman J, Makela JP, et al. [F-18]FDG-PET and whole-scalp MEG localization of epileptogenic cortex EPILEPSIA. 1999 JUL; 40 (7): 921-930	5	34	26	55
525	8191 Spillantini MG, Van Swieten JC, Goedert M Tau gene mutations in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) NEUROGENETICS. 2000 MAR; 2 (4): 193-205	19	67	26	92
526	8429 Spanaki MV, Kopylev L, DeCarli C, Gaillard WD, Liow K, et al. Postoperative changes in cerebral metabolism in temporal lobe epilepsy ARCHIVES OF NEUROLOGY. 2000 OCT; 57 (10): 1447-1452	16	42	26	45
527	8619 Ketter TA, Kimbrell TA, George MS, Dunn RT, Speer AM, et al. Effects of mood and subtype on cerebral glucose metabolism in treatment-resistant bipolar disorder BIOLOGICAL PSYCHIATRY. 2001 JAN 15; 49 (2): 97-109	10	132	26	103
528	9045 Buck A, Kamel E Clinical impact of F-18-fluorodeoxyglucose positron emission tomography in the diagnosis of neurological diseases ACTA MEDICA AUSTRIACA. 2002; 29 (5): 156-161	0	0	26	50
529	9121 Schelbert HR F-18-deoxyglucose and the assessment of myocardial viability SEMINARS IN NUCLEAR MEDICINE. 2002 JAN; 32 (1): 60-69	6	18	26	77
530	9366 Lee SK, Lee DS, Yeo JS, Lee JS, Kim YK, et al. FDG-PET images quantified by probabilistic atlas of brain and surgical prognosis of temporal lobe epilepsy EPILEPSIA. 2002 SEP; 43 (9): 1032-1038	4	12	26	34
#	Date / Author / Journal	LCS	GCS	LCR	CR
531	9708 Hammers A, Koepp MJ, Richardson MP, Hurlemann R, Brooks DJ, et al. Grey and white matter flumazenil binding in neocortical epilepsy with normal MRI. A PET study of 44 patients BRAIN. 2003 JUN; 126: 1300-1318	15	38	26	76
532	10207 Nagano-Saito A, Kato T, Arahata Y, Washimi Y, Nakamura A, et al. Cognitive- and motor-related regions in Parkinson's disease: FDOPA and FDG PET studies NEUROIMAGE. 2004 JUN; 22 (2): 553-561	9	27	26	93
533	10303 Laureys S, Owen AM, Schiff ND Brain function in coma, vegetative state, and related disorders LANCET NEUROLOGY. 2004 SEP; 3 (9): 537-546	7	170	26	115
534	10521 Chetelat G, Eustache F, Viader F, De la Sayette V, Pelerin A, et al. FDG-PET measurement is more accurate than neuropsychological assessments to predict global cognitive deterioration in patients with mild cognitive impairment NEUROCASE. 2005 FEB; 11 (1): 14-25	15	46	26	82
535	10640 Bentourkia M Kinetic modeling of PET data without blood sampling IEEE TRANSACTIONS ON NUCLEAR SCIENCE. 2005 JUN; 52 (3): 697-702	4	6	26	52
536	10759 Schwaiger M, Ziegler S, Nekolla SG PET/CT: Challenge for nuclear cardiology JOURNAL OF NUCLEAR MEDICINE. 2005 OCT; 46 (10): 1664-1678	9	38	26	131
537	11480 Venneri A Imaging treatment effects in Alzheimer's disease MAGNETIC RESONANCE IMAGING. 2007 JUL; 25 (6): 953-968	1	12	26	91
538	11522 Dawson HN, Cantillana V, Chen L, Vitek MP The tau N279K Exon 10 splicing mutation recapitulates frontotemporal dementia and parkinsonism linked to chromosome 17 tauopathy in a mouse model JOURNAL OF NEUROSCIENCE. 2007 AUG 22; 27 (34): 9155-9168	0	12	26	112
539	11557 Matsuda H Progress in neuroimaging of Alzheimer's disease PSYCHOGERIATRICS. 2007 SEP; 7 (3): 118-124	0	4	26	43
540	11689 Luat AF, Chugani HT Molecular and diffusion tensor imaging of epileptic networks EPILEPSIA. 2008; 49: 15-22	0	10	26	75
#	Date / Author / Journal	LCS	GCS	LCR	CR
541	11721 Foster NL, Wanga AY, Tasdizen T, Fletcher PT, Hoffman JM, et al. Realizing the potential of positron emission tomography with F-18- fluorodeoxyglucose to improve the treatment of Alzheimer's disease ALZHEIMERS & DEMENTIA. 2008 JAN; 4 (1): S29-S36	6	7	26	46
542	11772 Small GW, Bookheimer SY, Thompson PM, Cole GM, Huang SC, et al. Current and future uses of neuroimaging for cognitively impaired patients LANCET NEUROLOGY. 2008 FEB; 7 (2): 161-172	4	34	26	128
543	11850 Borghammer P, Jonsdottir KY, Cumming P, Ostergaard K, Vang K, et al. Normalization in PET group comparison studies - The importance of a valid reference region NEUROIMAGE. 2008 APR 1; 40 (2): 529-540	4	11	26	59
544	11981 Widjaja E, Raybaud C Advances in neuroimaging in patients with epilepsy NEUROSURGICAL FOCUS. 2008 SEP; 25 (3): Art. No. E3	0	6	26	140
545	12087 Pihlajamaki M, Sperling RA Functional MRI assessment of task-induced deactivation of the default mode network in Alzheimer's disease and at-risk older individuals BEHAVIOURAL NEUROLOGY. 2009; 21 (1-2): 77-91	0	5	26	96
546	12101 Van Boven RW, Harrington GS, Hackney DB, Ebel A, Gauger G, et al. Advances in neuroimaging of traumatic brain injury and posttraumatic stress disorder JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT. 2009; 46 (6): 717-755	0	3	26	344
547	12701 Beanlands RSB, Youssef G Diagnosis and prognosis of coronary artery disease: PET is superior to SPECT: Pro JOURNAL OF NUCLEAR CARDIOLOGY. 2010 AUG; 17 (4): 683-695	0	0	26	54
548	1223 RAICHLE ME POSITRON EMISSION TOMOGRAPHY ANNUAL REVIEW OF NEUROSCIENCE. 1983; 6: 249-267	32	70	25	61
549	1823 PIEZ CW, HOLMAN BL SINGLE PHOTON-EMISSION COMPUTED-TOMOGRAPHY COMPUTERIZED RADIOLOGY. 1985; 9 (4): 201-211	0	3	25	56
550	2117 SCHELBERT HR FEATURES OF POSITRON EMISSION TOMOGRAPHY AS A PROBE FOR MYOCARDIAL CHEMISTRY EUROPEAN JOURNAL OF NUCLEAR MEDICINE. 1986; 12: S2-S10	0	5	25	76
#	Date / Author / Journal	LCS	GCS	LCR	CR
551	2163 EVANS AC, DIKSIC M, YAMAMOTO YL, KATO A, DAGHER A, et al. EFFECT OF VASCULAR ACTIVITY IN THE DETERMINATION OF RATE CONSTANTS FOR THE UPTAKE OF F-18 LABELED 2-FLUORO-2-DEOXY-D-GLUCOSE - ERROR ANALYSIS AND NORMAL VALUES IN OLDER SUBJECTS JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 1986; 6 (6): 724-738	47	60	25	37
552	2254 BROOKS DJ, BEANEY RP, THOMAS DGT THE ROLE OF POSITRON EMISSION TOMOGRAPHY IN THE STUDY OF CEREBRAL- TUMORS SEMINARS IN ONCOLOGY. 1986 MAR; 13 (1): 83-93	6	34	25	62
553	2505 MARTIN WRW THE CONTRIBUTION OF PET SCANNING TO UNDERSTANDING METABOLISM AND DRUG ACTIONS IN THE BASAL GANGLIA PHARMACOLOGY & THERAPEUTICS. 1987; 32 (1): 77-87	1	2	25	74
554	2993 EVANS AC, BEIL C, MARRETT S, THOMPSON CJ, HAKIM A ANATOMICAL-FUNCTIONAL CORRELATION USING AN ADJUSTABLE MRI-BASED REGION OF INTEREST ATLAS WITH POSITRON EMISSION TOMOGRAPHY JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 1988 AUG; 8 (4): 513-530	57	178	25	49
555	3194 SCHUSTER DP POSITRON EMISSION TOMOGRAPHY - THEORY AND ITS APPLICATION TO THE STUDY OF LUNG-DISEASE AMERICAN REVIEW OF RESPIRATORY DISEASE. 1989 MAR; 139 (3): 818-840	2	64	25	157
556	3197 BAXTER LR, SCHWARTZ JM, PHELPS ME, MAZZIOTTA JC, GUZE BH, et al. REDUCTION OF PREFRONTAL CORTEX GLUCOSE-METABOLISM COMMON TO 3 TYPES OF DEPRESSION ARCHIVES OF GENERAL PSYCHIATRY. 1989 MAR; 46 (3): 243-250	142	806	25	82
557	3245 GOULD KL, GOLDSTEIN RA, MULLANI NA ECONOMIC-ANALYSIS OF CLINICAL POSITRON EMISSION TOMOGRAPHY OF THE HEART WITH RUBIDIUM-82 JOURNAL OF NUCLEAR MEDICINE. 1989 MAY; 30 (5): 707-717	24	40	25	74
558	3716 ENGEL J THE BERGER,HANS LECTURE - FUNCTIONAL EXPLORATIONS OF THE HUMAN EPILEPTIC BRAIN AND THEIR THERAPEUTIC IMPLICATIONS ELECTROENCEPHALOGRAPHY AND CLINICAL NEUROPHYSIOLOGY. 1990 OCT; 76 (4): 296-316	14	61	25	112
559	3853 HABERT MO, SPAMPINATO U, MAS JL, PIKETTY ML, BOURDEL MC, et al. A COMPARATIVE TC-99M HEXAMETHYLPROPYLENE AMINE OXIME SPET STUDY IN DIFFERENT TYPES OF DEMENTIA EUROPEAN JOURNAL OF NUCLEAR MEDICINE. 1991 JAN; 18 (1): 3-11	22	53	25	68
560	3901 HERHOLZ K, HEISS WD POSITRON EMISSION TOMOGRAPHY FOR THE IMAGING OF THE PATHOPHYSIOLOGY OF CEREBRAL-ISCHEMIA ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH. 1991 MAR; 41-1 (3A): 298-303	0	1	25	52
#	Date / Author / Journal	LCS	GCS	LCR	CR
561	4158 RYVLIN P, CINOTTI L, FROMENT JC, LEBARS D, LANDAIS P, et al. METABOLIC PATTERNS ASSOCIATED WITH NONSPECIFIC MAGNETIC-RESONANCE- IMAGING ABNORMALITIES IN TEMPORAL-LOBE EPILEPSY BRAIN. 1991 DEC; 114: 2363-2383	32	50	25	53
562	4191 ENGEL J, HENRY TR, RISINGER MW, SUTHERLING WW, CHUGANI HT PET IN RELATION TO INTRACRANIAL ELECTRODE EVALUATIONS EPILEPSY RESEARCH. 1992; : 111-120	0	0	25	50
563	4530 BARON JC, LEVASSEUR M, MAZOYER B, LEGAULTDEMARE F, MAUGUIERE F, et al. THALAMOCORTICAL DIASCHISIS - POSITRON EMISSION TOMOGRAPHY IN HUMANS JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. 1992 OCT; 55 (10): 935-942	35	95	25	37
564	4589 WOLKIN A, SANFILIPO M, WOLF AP, ANGRIST B, BRODIE JD, et al. NEGATIVE SYMPTOMS AND HYPOFRONTALITY IN CHRONIC-SCHIZOPHRENIA ARCHIVES OF GENERAL PSYCHIATRY. 1992 DEC; 49 (12): 959-965	19	249	25	55
565	4890 HOH CK, HAWKINS RA, GLASPY JA, DAHLBOM M, TSE NY, et al. CANCER-DETECTION WITH WHOLE-BODY PET USING 2-[F-18]FLUORO-2-DEOXY-D- GLUCOSE JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY. 1993 JUL-AUG; 17 (4): 582-589	30	195	25	41
566	5758 KUMLIEN E, BERGSTROM M, LILJA A, ANDERSSON J, SZEKERES V, et al. POSITRON EMISSION TOMOGRAPHY WITH [C-11] DEUTERIUM-DEPRENYL IN TEMPORAL-LOBE EPILEPSY EPILEPSIA. 1995 JUL; 36 (7): 712-721	15	25	25	57
567	5761 BLOMQVIST G, LAMMERTSMA AA, MAZOYER B, WIENHARD K EFFECT OF TISSUE HETEROGENEITY ON QUANTIFICATION IN POSITRON EMISSION TOMOGRAPHY EUROPEAN JOURNAL OF NUCLEAR MEDICINE. 1995 JUL; 22 (7): 652-663	4	19	25	40
568	5770 MARKAND ON, ANDERSEN AR, SPENCER SS SPECT IN EPILEPSY JOURNAL OF NEUROIMAGING. 1995 JUL; 5: S23-S33	3	7	25	42
569	5783 MINOSHIMA S, FREY KA, KOEPPE RA, FOSTER NL, KUHL DE A DIAGNOSTIC-APPROACH IN ALZHEIMERS-DISEASE USING 3-DIMENSIONAL STEREOTAXIC SURFACE PROJECTIONS OF FLUORINE-18-FDG PET JOURNAL OF NUCLEAR MEDICINE. 1995 JUL; 36 (7): 1238-1248	331	331	25	45
570	5844 YACUBIAN EMT, YAMAGA LYI, VALERIO RMF, FIORE LA, JORGE CL, et al. SINGLE-PHOTON EMISSION TOMOGRAPHY IN TEMPORAL-LOBE EPILEPSY - VISUAL AND SEMI QUANTITATIVE-ANALYSIS IN INTERICTAL AND ICTAL STUDIES ARQUIVOS DE NEURO-PSIQUIATRIA. 1995 SEP; 53 (3A): 369-383	0	0	25	45
#	Date / Author / Journal	LCS	GCS	LCR	CR
571	5879 VILLRINGER A, DIRNAGL U COUPLING OF BRAIN ACTIVITY AND CEREBRAL BLOOD-FLOW - BASIS OF FUNCTIONAL NEUROIMAGING CEREBROVASCULAR AND BRAIN METABOLISM REVIEWS. 1995 FAL; 7 (3): 240-276	19	322	25	264
572	5983 Gulyas B, Tron L, Balkay L, Emri M, Molnar T, et al. Regional glucose metabolic rates in the human brain: A PET study ACTA BIOLOGICA HUNGARICA. 1996; 47 (1-4): 157-172	3	6	25	45
573	6168 Reske SN, Bares R, Bull U, Guhlmann A, Moser E, et al. Clinical value of positron emission tomography (PET) in oncology: Results of an interdisciplinary consensus conference NUKLEARMEDIZIN. 1996 APR; 35 (2): 42-52	7	74	25	98
574	6270 Piert M, Koeppe RA, Giordani B, Minoshima S, Kuhl DE Determination of regional rate constants from dynamic FDG-PET studies in Parkinson's disease JOURNAL OF NUCLEAR MEDICINE. 1996 JUL; 37 (7): 1115-1122	26	26	25	44
575	6651 WoltersGeldof MJA, Cats VM, Bruschke AVG Clinical methods to determine coronary flow and myocardial perfusion INTERNATIONAL JOURNAL OF CARDIAC IMAGING. 1997 APR; 13 (2): 79-94	1	2	25	115
576	7013 Stein DJ, Buchsbaum MS, Hof PR, Siegel BV, Shihabuddin L Greater metabolic rate decreases in hippocampal formation and proisocortex than in neocortex in Alzheimer's disease NEUROPSYCHOBIOLOGY. 1998; 37 (1): 10-19	11	33	25	57
577	7221 Cornford EM, Gee MN, Swartz BE, Mandelkern MA, Blahd WH, et al. Dynamic [F-18]fluorodeoxyglucose positron emission tomography and hypometabolic zones in seizures: Reduced capillary influx ANNALS OF NEUROLOGY. 1998 JUN; 43 (6): 801-808	4	22	25	46
578	7380 Links JM Special issues in quantitation of brain receptors and related markers by emission computed tomography QUARTERLY JOURNAL OF NUCLEAR MEDICINE. 1998 SEP; 42 (3): 158-165	0	4	25	56
579	7493 Andrews TC, Brooks DJ Advances in the understanding of early Huntington's disease using the functional imaging techniques of PET and SPET MOLECULAR MEDICINE TODAY. 1998 DEC; 4 (12): 532-539	4	23	25	58
580	7628 Parker F, Levesque MF Presurgical contribution of quantitative stereotactic positron emission tomography in temporo limbic epilepsy SURGICAL NEUROLOGY. 1999 FEB; 51 (2): 202-210	0	1	25	53
#	Date / Author / Journal	LCS	GCS	LCR	CR
581	7704 Bartenstein P Positron-emission-tomography in neurology and psychiatry: clinical applications NERVENHEILKUNDE. 1999 APR; 18 (3): 132-138	1	2	25	51
582	7796 Gouzoulis-Mayfrank E, Schreckenberger M, Sabri O, Arning C, Thelen B, et al. Neurometabolic effects of psilocybin, 3,4- methylenedioxyethylamphetamine (MDE) and d-methamphetamine in healthy volunteers - A double-blind, placebo-controlled PET study with [F- 18]FDG NEUROPSYCHOPHARMACOLOGY. 1999 JUN; 20 (6): 565-581	4	44	25	88
583	7961 Leslie WD, Greenberg CR, Abrams DN, Hobson D Clinical deficits in Huntington disease correlate with reduced striatal uptake on iodine-123 epidepride single-photon emission tomography EUROPEAN JOURNAL OF NUCLEAR MEDICINE. 1999 NOV; 26 (11): 1458-1464	0	2	25	48
584	7964 Hustinx R, Smith RJ, Benard F, Bhatnagar A, Alavi A Can the standardized uptake value characterize primary brain tumors on FDG-PET? EUROPEAN JOURNAL OF NUCLEAR MEDICINE. 1999 NOV; 26 (11): 1501-1509	8	39	25	51
585	8060 Gaillard WD Structural and functional imaging in children with partial epilepsy MENTAL RETARDATION AND DEVELOPMENTAL DISABILITIES RESEARCH REVIEWS. 2000; 6 (3): 220-226	0	6	25	92
586	8193 Barrington SF Clinical uses of PET in neurology NUCLEAR MEDICINE COMMUNICATIONS. 2000 MAR; 21 (3): 237-240	1	3	25	40
587	8420 Juhasz C, Chugani DC, Muzik O, Watson C, Shah J, et al. Electroclinical correlates of flumazenil and fluorodeoxyglucose PET abnormalities in lesional epilepsy NEUROLOGY. 2000 SEP 26; 55 (6): 825-834	21	46	25	53
588	8547 Santens P, De Bleecker J, Goethals P, Strijckmans K, Lemahieu I, et al. Differential regional cerebral uptake of F-18-fluoro-2-deoxy-D-glucose in Alzheimer's disease and frontotemporal dementia at initial diagnosis EUROPEAN NEUROLOGY. 2001; 45 (1): 19-27	11	23	25	48
589	8565 Goedert M, Spillantini MG Tau gene mutations and neurodegeneration NEURONAL SIGNAL TRANSDUCTION AND ALZHEIMER'S DISEASE. 2001; (67): 59-71	0	1	25	85
590	8897 Farkas E, Luiten PGM Cerebral microvascular pathology in aging and Alzheimer's disease PROGRESS IN NEUROBIOLOGY. 2001 AUG; 64 (6): 575-611	8	266	25	277
#	Date / Author / Journal	LCS	GCS	LCR	CR
591	9202 Vandermeeren Y, Olivier E, Sebire G, Cosnard G, Bol A, et al. Increased FDG uptake in the ipsilesional sensorimotor cortex in congenital hemiplegia NEUROIMAGE. 2002 APR; 15 (4): 949-960	1	8	25	93
592	9459 Rosen AC, Bokde ALW, Pearl A, Yesavage JA Ethical, and practical issues in applying functional imaging to the clinical management of Alzheimer's disease BRAIN AND COGNITION. 2002 DEC; 50 (3): 498-519	1	8	25	117
593	9467 Drevets WC, Bogers W, Raichle ME Functional anatomical correlates of antidepressant drug treatment assessed using PET measures of regional glucose metabolism EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2002 DEC; 12 (6): 527-544	6	167	25	140
594	9553 Wszolek ZK, Tsuboi Y, Farrer M, Uitti RJ, Hutton ML Hereditary tauopathies and parkinsonism PARKINSON'S DISEASE. 2003; 91: 153-163	8	15	25	49
595	9592 Goethals I, Wiele C, Boon P, Dierckx R Is central benzodiazepine receptor imaging useful for the identification of epileptogenic foci in localization-related epilepsies? EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2003 FEB; 30 (2): 325-328	4	12	25	40
596	10023 Chassoux F, Semah F, Bouilleret V, Landre E, Devaux B, et al. Metabolic changes and electro-clinical patterns in mesio-temporal lobe epilepsy: a correlative study BRAIN. 2004 JAN; 127: 164-174	19	57	25	54
597	10076 Novak L, Emri M, Molnar P, Balkay L, Lengyel Z, et al. Subcortical [F-18]fluorodeoxyglucose uptake in lesional epilepsy in patients with intracranial tumour NUCLEAR MEDICINE COMMUNICATIONS. 2004 FEB; 25 (2): 123-128	0	0	25	56
598	10411 Mason NS, Mathis CA Positron emission tomography agents for central nervous system drug development applications ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 40. 2005; 40: 49-68	0	4	25	123
599	10422 Ryvlin P, Montavont A, Arzimanoglou A What future for neuroimaging techniques in evaluating cognition in children COGNITIVE DYSFUNCTION IN CHILDREN WITH TEMPORAL LOBE EPILEPSY. 2005; 1: 141-152	0	0	25	121
600	10480 Pupi A, Mosconi L, Nobili FM, Sorbi S Toward the validation of functional neuroimaging as a potential biomarker for Alzheimer's disease: implications for drug development MOLECULAR IMAGING AND BIOLOGY. 2005 JAN-FEB; 7 (1): 59-68	1	7	25	53

Date / Author / Journal

LCS

GCS

LCR

501

9662 Zhou Y, Endres CJ, Brasic JR, Huang SC, Wong DF

Linear regression with spatial constraint to generate parametric images of ligand-receptor dynamic PET studies with a simplified reference tissue model

NEUROIMAGE. 2003 APR; 18 (4): 975-989

502

9812 Buchpiguel CA

The role of functional neuroimaging methods in focal epilepsy - Evaluation under normal structural imaging findings

ARQUIVOS DE NEURO-PSIQUIATRIA. 2003 SEP; 61: 88-92

503

9820 Sakamoto S, Tsuyuguchi N, Takami T, Morino M, Goto T, et al.

Interictal patterns of cerebral glucose metabolism, perfusion, and magnetic field in mesial temporal lobe epilepsy

EPILEPSIA. 2003 SEP; 44 (9): 1196-1206

504

10308 Holschneider DP, Maarek JMI

Mapping brain function in freely moving subjects

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS. 2004 SEP; 28 (5): 449-461

136

505

10487 Fischman AJ

Role of [F-18]-dopa-PET imaging in assessing movement disorders

RADIOLOGIC CLINICS OF NORTH AMERICA. 2005 JAN; 43 (1): 93-+

506

10656 Mosconi L, Tsui WH, De Santi S, Li J, Rusinek H, et al.

Reduced hippocampal metabolism in MCI and AD - Automated FDG-PET image analysis

NEUROLOGY. 2005 JUN 14; 64 (11): 1860-1867

507

11653 Matsuda H

The role of neuroimaging in mild cognitive impairment

NEUROPATHOLOGY. 2007 DEC; 27 (6): 570-577

508

11820 Liang WS, Reiman EM, Valla J, Dunckley T, Beach TG, et al.

Alzheimer's disease is associated with reduced expression of energy in posterior cingulate metabolism genes neurons

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2008 MAR 18; 105 (11): 4441-4446

509

11947 Goldman S

Molecular imaging of dementia: Which means for which questions?

MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE. 2008 AUG; 32 (8): 439-445

510

12130 Le Forestier N, Lacomblez L, Meininger V

Parkinson disease and amyotrophic lateral sclerosis Tauopathies, TDP-43 and SOD mutations

REVUE NEUROLOGIQUE. 2009 JAN; 165 (1): 15-30

258

Date / Author / Journal

LCS

GCS

LCR

511

12699 Klein R, Beanlands RSB, deKemp RA

Quantification of myocardial blood flow and flow reserve: Technical aspects

JOURNAL OF NUCLEAR CARDIOLOGY. 2010 AUG; 17 (4): 555-570

512

1484 FARKAS T, WOLF AP, JAEGER J, BRODIE JD, CHRISTMAN DR, et al.

REGIONAL BRAIN GLUCOSE-METABOLISM IN CHRONIC-SCHIZOPHRENIA - A POSITRON EMISSION TRANSAXIAL TOMOGRAPHIC STUDY

ARCHIVES OF GENERAL PSYCHIATRY. 1984; 41 (3): 293-300

184

513

2058 ESSER PD

IMPROVEMENTS IN SPECT TECHNOLOGY FOR CEREBRAL IMAGING

SEMINARS IN NUCLEAR MEDICINE. 1985; 15 (4): 335-346

514

3301 SETTE G, BARON JC, MAZOYER B, LEVASSEUR M, PAPPATA S, et al.

LOCAL BRAIN HEMODYNAMICS AND OXYGEN-METABOLISM IN CEREBROVASCULAR- DISEASE - POSITRON EMISSION TOMOGRAPHY

BRAIN. 1989 AUG; 112: 931-951

124

515

3415 VAUPEL P, KALLINOWSKI F, OKUNIEFF P

BLOOD-FLOW, OXYGEN AND NUTRIENT SUPPLY, AND METABOLIC MICROENVIRONMENT OF HUMAN-TUMORS - A REVIEW

CANCER RESEARCH. 1989 DEC 1; 49 (23): 6449-6465

1473

214

516

3627 BLIN J, BARON JC, DUBOIS B, PILLON B, CAMBON H, et al.

POSITRON EMISSION TOMOGRAPHY STUDY IN PROGRESSIVE SUPRANUCLEAR PALSY - BRAIN HYPOMETABOLIC PATTERN AND CLINICOMETABOLIC CORRELATIONS

ARCHIVES OF NEUROLOGY. 1990 JUL; 47 (7): 747-752

172

517

3726 KUNG HF, OHMOMO Y, KUNG MP

CURRENT AND FUTURE RADIOPHARMACEUTICALS FOR BRAIN IMAGING WITH SINGLE PHOTON-EMISSION COMPUTED-TOMOGRAPHY

SEMINARS IN NUCLEAR MEDICINE. 1990 OCT; 20 (4): 290-302

129

518

4084 ALTMAN DI, VOLPE JJ

POSITRON EMISSION TOMOGRAPHY IN NEWBORN-INFANTS

CLINICS IN PERINATOLOGY. 1991 SEP; 18 (3): 549-562

519

4131 KUWERT T, HENNERICI M, LANGEN KJ, AULICH A, HERZOG H, et al.

REGIONAL CEREBRAL GLUCOSE CONSUMPTION MEASURED BY POSITRON EMISSION TOMOGRAPHY IN PATIENTS WITH UNILATERAL THALAMIC INFARCTION

CEREBROVASCULAR DISEASES. 1991 NOV-DEC; 1 (6): 327-336

520

4464 CHUGANI HT

FUNCTIONAL BRAIN IMAGING IN PEDIATRICS

PEDIATRIC CLINICS OF NORTH AMERICA. 1992 AUG; 39 (4): 777-799

Date / Author / Journal

LCS

GCS

LCR

521

5205 COOK MJ, KILPATRICK C

IMAGING IN EPILEPSY

CURRENT OPINION IN NEUROLOGY. 1994 APR; 7 (2): 123-130

522

5530 STOPPE G, STAEDT J, KOGLER A, SCHUTZE R, KUNERT HJ, et al.

TC-99M-HMPAO-SPECT IN THE DIAGNOSIS OF SENILE DEMENTIA OF ALZHEIMERS TYPE - A STUDY UNDER CLINICAL ROUTINE CONDITIONS

JOURNAL OF NEURAL TRANSMISSION-GENERAL SECTION. 1995; 99 (1-3): 195-211

523

6314 Meltzer CC, Zubieta JK, Brandt J, Tune LE, Mayberg HS, et al.

Regional hypometabolism in Alzheimer's disease as measured by positron emission tomography after correction for effects of partial volume averaging

NEUROLOGY. 1996 AUG; 47 (2): 454-461

104

524

7820 Lamusuo S, Forss N, Ruottinen HM, Bergman J, Makela JP, et al.

[F-18]FDG-PET and whole-scalp MEG localization of epileptogenic cortex

EPILEPSIA. 1999 JUL; 40 (7): 921-930

525

8191 Spillantini MG, Van Swieten JC, Goedert M

Tau gene mutations in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17)

NEUROGENETICS. 2000 MAR; 2 (4): 193-205

526

8429 Spanaki MV, Kopylev L, DeCarli C, Gaillard WD, Liow K, et al.

Postoperative changes in cerebral metabolism in temporal lobe epilepsy

ARCHIVES OF NEUROLOGY. 2000 OCT; 57 (10): 1447-1452

527

8619 Ketter TA, Kimbrell TA, George MS, Dunn RT, Speer AM, et al.

Effects of mood and subtype on cerebral glucose metabolism in treatment-resistant bipolar disorder

BIOLOGICAL PSYCHIATRY. 2001 JAN 15; 49 (2): 97-109

132

103

528

9045 Buck A, Kamel E

Clinical impact of F-18-fluorodeoxyglucose positron emission tomography in the diagnosis of neurological diseases

ACTA MEDICA AUSTRIACA. 2002; 29 (5): 156-161

529

9121 Schelbert HR

F-18-deoxyglucose and the assessment of myocardial viability

SEMINARS IN NUCLEAR MEDICINE. 2002 JAN; 32 (1): 60-69

530

9366 Lee SK, Lee DS, Yeo JS, Lee JS, Kim YK, et al.

FDG-PET images quantified by probabilistic atlas of brain and surgical prognosis of temporal lobe epilepsy

EPILEPSIA. 2002 SEP; 43 (9): 1032-1038

Date / Author / Journal

LCS

GCS

LCR

531

9708 Hammers A, Koepp MJ, Richardson MP, Hurlemann R, Brooks DJ, et al.

Grey and white matter flumazenil binding in neocortical epilepsy with normal MRI. A PET study of 44 patients

BRAIN. 2003 JUN; 126: 1300-1318

532

10207 Nagano-Saito A, Kato T, Arahata Y, Washimi Y, Nakamura A, et al.

Cognitive- and motor-related regions in Parkinson's disease: FDOPA and FDG PET studies

NEUROIMAGE. 2004 JUN; 22 (2): 553-561

533

10303 Laureys S, Owen AM, Schiff ND

Brain function in coma, vegetative state, and related disorders

LANCET NEUROLOGY. 2004 SEP; 3 (9): 537-546

170

115

534

10521 Chetelat G, Eustache F, Viader F, De la Sayette V, Pelerin A, et al.

FDG-PET measurement is more accurate than neuropsychological assessments to predict global cognitive deterioration in patients with mild cognitive impairment

NEUROCASE. 2005 FEB; 11 (1): 14-25

535

10640 Bentourkia M

Kinetic modeling of PET data without blood sampling

IEEE TRANSACTIONS ON NUCLEAR SCIENCE. 2005 JUN; 52 (3): 697-702

536

10759 Schwaiger M, Ziegler S, Nekolla SG

PET/CT: Challenge for nuclear cardiology

JOURNAL OF NUCLEAR MEDICINE. 2005 OCT; 46 (10): 1664-1678

131

537

11480 Venneri A

Imaging treatment effects in Alzheimer's disease

MAGNETIC RESONANCE IMAGING. 2007 JUL; 25 (6): 953-968

538

11522 Dawson HN, Cantillana V, Chen L, Vitek MP

The tau N279K Exon 10 splicing mutation recapitulates frontotemporal dementia and parkinsonism linked to chromosome 17 tauopathy in a mouse model

JOURNAL OF NEUROSCIENCE. 2007 AUG 22; 27 (34): 9155-9168

112

539

11557 Matsuda H

Progress in neuroimaging of Alzheimer's disease

PSYCHOGERIATRICS. 2007 SEP; 7 (3): 118-124

540

11689 Luat AF, Chugani HT

Molecular and diffusion tensor imaging of epileptic networks

EPILEPSIA. 2008; 49: 15-22

Date / Author / Journal

LCS

GCS

LCR

541

11721 Foster NL, Wanga AY, Tasdizen T, Fletcher PT, Hoffman JM, et al.

Realizing the potential of positron emission tomography with F-18- fluorodeoxyglucose to improve the treatment of Alzheimer's disease

ALZHEIMERS & DEMENTIA. 2008 JAN; 4 (1): S29-S36

542

11772 Small GW, Bookheimer SY, Thompson PM, Cole GM, Huang SC, et al.

Current and future uses of neuroimaging for cognitively impaired patients

LANCET NEUROLOGY. 2008 FEB; 7 (2): 161-172

128

543

11850 Borghammer P, Jonsdottir KY, Cumming P, Ostergaard K, Vang K, et al.

Normalization in PET group comparison studies - The importance of a valid reference region

NEUROIMAGE. 2008 APR 1; 40 (2): 529-540

544

11981 Widjaja E, Raybaud C

Advances in neuroimaging in patients with epilepsy

NEUROSURGICAL FOCUS. 2008 SEP; 25 (3): Art. No. E3

140

545

12087 Pihlajamaki M, Sperling RA

Functional MRI assessment of task-induced deactivation of the default mode network in Alzheimer's disease and at-risk older individuals

BEHAVIOURAL NEUROLOGY. 2009; 21 (1-2): 77-91

546

12101 Van Boven RW, Harrington GS, Hackney DB, Ebel A, Gauger G, et al.

Advances in neuroimaging of traumatic brain injury and posttraumatic stress disorder

JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT. 2009; 46 (6): 717-755

344

547

12701 Beanlands RSB, Youssef G

Diagnosis and prognosis of coronary artery disease: PET is superior to SPECT: Pro

JOURNAL OF NUCLEAR CARDIOLOGY. 2010 AUG; 17 (4): 683-695

548

1223 RAICHLE ME

POSITRON EMISSION TOMOGRAPHY

ANNUAL REVIEW OF NEUROSCIENCE. 1983; 6: 249-267

549

1823 PIEZ CW, HOLMAN BL

SINGLE PHOTON-EMISSION COMPUTED-TOMOGRAPHY

COMPUTERIZED RADIOLOGY. 1985; 9 (4): 201-211

550

2117 SCHELBERT HR

FEATURES OF POSITRON EMISSION TOMOGRAPHY AS A PROBE FOR MYOCARDIAL CHEMISTRY

EUROPEAN JOURNAL OF NUCLEAR MEDICINE. 1986; 12: S2-S10

Date / Author / Journal

LCS

GCS

LCR

551

2163 EVANS AC, DIKSIC M, YAMAMOTO YL, KATO A, DAGHER A, et al.

EFFECT OF VASCULAR ACTIVITY IN THE DETERMINATION OF RATE CONSTANTS FOR THE UPTAKE OF F-18 LABELED 2-FLUORO-2-DEOXY-D-GLUCOSE - ERROR ANALYSIS AND NORMAL VALUES IN OLDER SUBJECTS

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 1986; 6 (6): 724-738

552

2254 BROOKS DJ, BEANEY RP, THOMAS DGT

THE ROLE OF POSITRON EMISSION TOMOGRAPHY IN THE STUDY OF CEREBRAL- TUMORS

SEMINARS IN ONCOLOGY. 1986 MAR; 13 (1): 83-93

553

2505 MARTIN WRW

THE CONTRIBUTION OF PET SCANNING TO UNDERSTANDING METABOLISM AND DRUG ACTIONS IN THE BASAL GANGLIA

PHARMACOLOGY & THERAPEUTICS. 1987; 32 (1): 77-87

554

2993 EVANS AC, BEIL C, MARRETT S, THOMPSON CJ, HAKIM A

ANATOMICAL-FUNCTIONAL CORRELATION USING AN ADJUSTABLE MRI-BASED REGION OF INTEREST ATLAS WITH POSITRON EMISSION TOMOGRAPHY

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 1988 AUG; 8 (4): 513-530

178

555

3194 SCHUSTER DP

POSITRON EMISSION TOMOGRAPHY - THEORY AND ITS APPLICATION TO THE STUDY OF LUNG-DISEASE

AMERICAN REVIEW OF RESPIRATORY DISEASE. 1989 MAR; 139 (3): 818-840

157

556

3197 BAXTER LR, SCHWARTZ JM, PHELPS ME, MAZZIOTTA JC, GUZE BH, et al.

REDUCTION OF PREFRONTAL CORTEX GLUCOSE-METABOLISM COMMON TO 3 TYPES OF DEPRESSION

ARCHIVES OF GENERAL PSYCHIATRY. 1989 MAR; 46 (3): 243-250

142

806

557

3245 GOULD KL, GOLDSTEIN RA, MULLANI NA

ECONOMIC-ANALYSIS OF CLINICAL POSITRON EMISSION TOMOGRAPHY OF THE HEART WITH RUBIDIUM-82

JOURNAL OF NUCLEAR MEDICINE. 1989 MAY; 30 (5): 707-717

558

3716 ENGEL J

THE BERGER,HANS LECTURE - FUNCTIONAL EXPLORATIONS OF THE HUMAN EPILEPTIC BRAIN AND THEIR THERAPEUTIC IMPLICATIONS

ELECTROENCEPHALOGRAPHY AND CLINICAL NEUROPHYSIOLOGY. 1990 OCT; 76 (4): 296-316

112

559

3853 HABERT MO, SPAMPINATO U, MAS JL, PIKETTY ML, BOURDEL MC, et al.

A COMPARATIVE TC-99M HEXAMETHYLPROPYLENE AMINE OXIME SPET STUDY IN DIFFERENT TYPES OF DEMENTIA

EUROPEAN JOURNAL OF NUCLEAR MEDICINE. 1991 JAN; 18 (1): 3-11

560

3901 HERHOLZ K, HEISS WD

POSITRON EMISSION TOMOGRAPHY FOR THE IMAGING OF THE PATHOPHYSIOLOGY OF CEREBRAL-ISCHEMIA

ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH. 1991 MAR; 41-1 (3A): 298-303

Date / Author / Journal

LCS

GCS

LCR

561

4158 RYVLIN P, CINOTTI L, FROMENT JC, LEBARS D, LANDAIS P, et al.

METABOLIC PATTERNS ASSOCIATED WITH NONSPECIFIC MAGNETIC-RESONANCE- IMAGING ABNORMALITIES IN TEMPORAL-LOBE EPILEPSY

BRAIN. 1991 DEC; 114: 2363-2383

562

4191 ENGEL J, HENRY TR, RISINGER MW, SUTHERLING WW, CHUGANI HT

PET IN RELATION TO INTRACRANIAL ELECTRODE EVALUATIONS

EPILEPSY RESEARCH. 1992; : 111-120

563

4530 BARON JC, LEVASSEUR M, MAZOYER B, LEGAULTDEMARE F, MAUGUIERE F, et al.

THALAMOCORTICAL DIASCHISIS - POSITRON EMISSION TOMOGRAPHY IN HUMANS

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. 1992 OCT; 55 (10): 935-942

564

4589 WOLKIN A, SANFILIPO M, WOLF AP, ANGRIST B, BRODIE JD, et al.

NEGATIVE SYMPTOMS AND HYPOFRONTALITY IN CHRONIC-SCHIZOPHRENIA

ARCHIVES OF GENERAL PSYCHIATRY. 1992 DEC; 49 (12): 959-965

249

565

4890 HOH CK, HAWKINS RA, GLASPY JA, DAHLBOM M, TSE NY, et al.

CANCER-DETECTION WITH WHOLE-BODY PET USING 2-[F-18]FLUORO-2-DEOXY-D- GLUCOSE

JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY. 1993 JUL-AUG; 17 (4): 582-589

195

566

5758 KUMLIEN E, BERGSTROM M, LILJA A, ANDERSSON J, SZEKERES V, et al.

POSITRON EMISSION TOMOGRAPHY WITH [C-11] DEUTERIUM-DEPRENYL IN TEMPORAL-LOBE EPILEPSY

EPILEPSIA. 1995 JUL; 36 (7): 712-721

567

5761 BLOMQVIST G, LAMMERTSMA AA, MAZOYER B, WIENHARD K

EFFECT OF TISSUE HETEROGENEITY ON QUANTIFICATION IN POSITRON EMISSION TOMOGRAPHY

EUROPEAN JOURNAL OF NUCLEAR MEDICINE. 1995 JUL; 22 (7): 652-663

568

5770 MARKAND ON, ANDERSEN AR, SPENCER SS

SPECT IN EPILEPSY

JOURNAL OF NEUROIMAGING. 1995 JUL; 5: S23-S33

569

5783 MINOSHIMA S, FREY KA, KOEPPE RA, FOSTER NL, KUHL DE

A DIAGNOSTIC-APPROACH IN ALZHEIMERS-DISEASE USING 3-DIMENSIONAL STEREOTAXIC SURFACE PROJECTIONS OF FLUORINE-18-FDG PET

JOURNAL OF NUCLEAR MEDICINE. 1995 JUL; 36 (7): 1238-1248

331

570

5844 YACUBIAN EMT, YAMAGA LYI, VALERIO RMF, FIORE LA, JORGE CL, et al.

SINGLE-PHOTON EMISSION TOMOGRAPHY IN TEMPORAL-LOBE EPILEPSY - VISUAL AND SEMI QUANTITATIVE-ANALYSIS IN INTERICTAL AND ICTAL STUDIES

ARQUIVOS DE NEURO-PSIQUIATRIA. 1995 SEP; 53 (3A): 369-383

Date / Author / Journal

LCS

GCS

LCR

571

5879 VILLRINGER A, DIRNAGL U

COUPLING OF BRAIN ACTIVITY AND CEREBRAL BLOOD-FLOW - BASIS OF FUNCTIONAL NEUROIMAGING

CEREBROVASCULAR AND BRAIN METABOLISM REVIEWS. 1995 FAL; 7 (3): 240-276

322

264

572

5983 Gulyas B, Tron L, Balkay L, Emri M, Molnar T, et al.

Regional glucose metabolic rates in the human brain: A PET study

ACTA BIOLOGICA HUNGARICA. 1996; 47 (1-4): 157-172

573

6168 Reske SN, Bares R, Bull U, Guhlmann A, Moser E, et al.

Clinical value of positron emission tomography (PET) in oncology: Results of an interdisciplinary consensus conference

NUKLEARMEDIZIN. 1996 APR; 35 (2): 42-52

574

6270 Piert M, Koeppe RA, Giordani B, Minoshima S, Kuhl DE

Determination of regional rate constants from dynamic FDG-PET studies in Parkinson's disease

JOURNAL OF NUCLEAR MEDICINE. 1996 JUL; 37 (7): 1115-1122

575

6651 WoltersGeldof MJA, Cats VM, Bruschke AVG

Clinical methods to determine coronary flow and myocardial perfusion

INTERNATIONAL JOURNAL OF CARDIAC IMAGING. 1997 APR; 13 (2): 79-94

115

576

7013 Stein DJ, Buchsbaum MS, Hof PR, Siegel BV, Shihabuddin L

Greater metabolic rate decreases in hippocampal formation and proisocortex than in neocortex in Alzheimer's disease

NEUROPSYCHOBIOLOGY. 1998; 37 (1): 10-19

577

7221 Cornford EM, Gee MN, Swartz BE, Mandelkern MA, Blahd WH, et al.

Dynamic [F-18]fluorodeoxyglucose positron emission tomography and hypometabolic zones in seizures: Reduced capillary influx

ANNALS OF NEUROLOGY. 1998 JUN; 43 (6): 801-808

578

7380 Links JM

Special issues in quantitation of brain receptors and related markers by emission computed tomography

QUARTERLY JOURNAL OF NUCLEAR MEDICINE. 1998 SEP; 42 (3): 158-165

579

7493 Andrews TC, Brooks DJ

Advances in the understanding of early Huntington's disease using the functional imaging techniques of PET and SPET

MOLECULAR MEDICINE TODAY. 1998 DEC; 4 (12): 532-539

580

7628 Parker F, Levesque MF

Presurgical contribution of quantitative stereotactic positron emission tomography in temporo limbic epilepsy

SURGICAL NEUROLOGY. 1999 FEB; 51 (2): 202-210

Date / Author / Journal

581

Positron-emission-tomography in neurology and psychiatry: clinical applications

NERVENHEILKUNDE. 1999 APR; 18 (3): 132-138

582

7796 Gouzoulis-Mayfrank E, Schreckenberger M, Sabri O, Arning C, Thelen B, et al.

Neurometabolic effects of psilocybin, 3,4- methylenedioxyethylamphetamine (MDE) and d-methamphetamine in healthy volunteers - A double-blind, placebo-controlled PET study with [F- 18]FDG

NEUROPSYCHOPHARMACOLOGY. 1999 JUN; 20 (6): 565-581

583

7961 Leslie WD, Greenberg CR, Abrams DN, Hobson D

Clinical deficits in Huntington disease correlate with reduced striatal uptake on iodine-123 epidepride single-photon emission tomography

EUROPEAN JOURNAL OF NUCLEAR MEDICINE. 1999 NOV; 26 (11): 1458-1464

584

7964 Hustinx R, Smith RJ, Benard F, Bhatnagar A, Alavi A

Can the standardized uptake value characterize primary brain tumors on FDG-PET?

EUROPEAN JOURNAL OF NUCLEAR MEDICINE. 1999 NOV; 26 (11): 1501-1509

585

8060 Gaillard WD

Structural and functional imaging in children with partial epilepsy

MENTAL RETARDATION AND DEVELOPMENTAL DISABILITIES RESEARCH REVIEWS. 2000; 6 (3): 220-226

586

8193 Barrington SF

Clinical uses of PET in neurology

NUCLEAR MEDICINE COMMUNICATIONS. 2000 MAR; 21 (3): 237-240

587

8420 Juhasz C, Chugani DC, Muzik O, Watson C, Shah J, et al.

Electroclinical correlates of flumazenil and fluorodeoxyglucose PET abnormalities in lesional epilepsy

NEUROLOGY. 2000 SEP 26; 55 (6): 825-834

588

8547 Santens P, De Bleecker J, Goethals P, Strijckmans K, Lemahieu I, et al.

Differential regional cerebral uptake of F-18-fluoro-2-deoxy-D-glucose in Alzheimer's disease and frontotemporal dementia at initial diagnosis

EUROPEAN NEUROLOGY. 2001; 45 (1): 19-27

589

8565 Goedert M, Spillantini MG

Tau gene mutations and neurodegeneration

NEURONAL SIGNAL TRANSDUCTION AND ALZHEIMER'S DISEASE. 2001; (67): 59-71

590

8897 Farkas E, Luiten PGM

Cerebral microvascular pathology in aging and Alzheimer's disease

PROGRESS IN NEUROBIOLOGY. 2001 AUG; 64 (6): 575-611

266

277

Date / Author / Journal

LCS

GCS

LCR

591

9202 Vandermeeren Y, Olivier E, Sebire G, Cosnard G, Bol A, et al.

Increased FDG uptake in the ipsilesional sensorimotor cortex in congenital hemiplegia

NEUROIMAGE. 2002 APR; 15 (4): 949-960

592

9459 Rosen AC, Bokde ALW, Pearl A, Yesavage JA

Ethical, and practical issues in applying functional imaging to the clinical management of Alzheimer's disease

BRAIN AND COGNITION. 2002 DEC; 50 (3): 498-519

117

593

9467 Drevets WC, Bogers W, Raichle ME

Functional anatomical correlates of antidepressant drug treatment assessed using PET measures of regional glucose metabolism

EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2002 DEC; 12 (6): 527-544

167

140

594

9553 Wszolek ZK, Tsuboi Y, Farrer M, Uitti RJ, Hutton ML

Hereditary tauopathies and parkinsonism

PARKINSON'S DISEASE. 2003; 91: 153-163

595

9592 Goethals I, Wiele C, Boon P, Dierckx R

Is central benzodiazepine receptor imaging useful for the identification of epileptogenic foci in localization-related epilepsies?

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2003 FEB; 30 (2): 325-328

596

10023 Chassoux F, Semah F, Bouilleret V, Landre E, Devaux B, et al.

Metabolic changes and electro-clinical patterns in mesio-temporal lobe epilepsy: a correlative study

BRAIN. 2004 JAN; 127: 164-174

597

10076 Novak L, Emri M, Molnar P, Balkay L, Lengyel Z, et al.

Subcortical [F-18]fluorodeoxyglucose uptake in lesional epilepsy in patients with intracranial tumour

NUCLEAR MEDICINE COMMUNICATIONS. 2004 FEB; 25 (2): 123-128

598

10411 Mason NS, Mathis CA

Positron emission tomography agents for central nervous system drug development applications

ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 40. 2005; 40: 49-68

123

599

10422 Ryvlin P, Montavont A, Arzimanoglou A

What future for neuroimaging techniques in evaluating cognition in children

COGNITIVE DYSFUNCTION IN CHILDREN WITH TEMPORAL LOBE EPILEPSY. 2005; 1: 141-152

121

600

10480 Pupi A, Mosconi L, Nobili FM, Sorbi S

Toward the validation of functional neuroimaging as a potential biomarker for Alzheimer's disease: implications for drug development

MOLECULAR IMAGING AND BIOLOGY. 2005 JAN-FEB; 7 (1): 59-68

DE Kuhl w/citing papers Publications by DE Kuhl and the papers citing DE Kuhl	Historiographs	Glossary HistCite Guide About Grand Totals: LCS 111881, GCS 497938, CR 637448 Collection span: 1956 - 2011
List of All Records